In a patient with persistently elevated parathyroid hormone, high‑normal serum calcium, and increased 24‑hour urinary calcium, are the neurological deficits, muscle weakness, hair loss, extreme fatigue, pancreatitis, and coordination problems caused by the excess calcium rather than the elevated parathyroid hormone?

The Symptoms Are Primarily Due to Hypercalcemia, Not PTH Itself

Your patient's neurological deficits, motor weakness, extreme fatigue, pancreatitis, and coordination problems are predominantly caused by the elevated calcium levels rather than the parathyroid hormone elevation alone. While both hypercalcemia and elevated PTH contribute to the pathophysiology of primary hyperparathyroidism (PHPT), the acute and severe manifestations you describe—particularly pancreatitis—are directly attributable to hypercalcemia 1.

Why Calcium Is the Primary Culprit

Pancreatitis

Hypercalcemia-induced pancreatitis is a well-established complication of PHPT. Even with "high-normal" serum calcium, the combination of elevated 24-hour urinary calcium indicates significant calcium dysregulation. Pancreatitis in PHPT is directly caused by hypercalcemia and represents a serious manifestation requiring urgent intervention 2, 3, 4. Studies show that PHPT-associated pancreatitis carries worse outcomes than other etiologies, with higher rates of severe acute pancreatitis (OR 3.73), ICU admission (OR 3.79), and mortality (OR 12.76) 5.

Neurological and Motor Symptoms

The neurological manifestations—including muscle weakness, fatigue, coordination issues—are primarily mediated by hypercalcemia's effects on:

• Sodium-potassium ATPase transporter function
• Neurotransmitter systems (monoamine oxidase, tyrosine hydroxylase)
• Neuroinflammation via interleukin-6 6

Severe hypercalcemia (>3.5 mmol/L) causes hypercalcemic crisis with muscle weakness, fatigue, and even coma 7, 8. Your patient's "high-normal" calcium may still be pathologically elevated in the context of PHPT, as the 2025 French consensus defines surgical indication as calcium >10 mg/L (0.25 mmol/L) above the upper normal limit 9.

The PTH Contribution

While elevated PTH does contribute to neuropsychiatric symptoms through effects on monoamine neurotransmission 6, the acute, life-threatening manifestations (pancreatitis, severe neurological dysfunction) are calcium-mediated. PTH's role is more relevant for chronic symptoms like depression, anxiety, and cognitive dysfunction that improve after parathyroidectomy 6.

Critical Clinical Implications

Your Patient Requires Urgent Surgical Evaluation

Based on the 2025 French expert consensus 9, surgery is indicated immediately given:

• Pancreatitis (a serious complication)
• Elevated 24-hour urinary calcium
• Neurological manifestations suggesting severe disease

The consensus states: "Surgery should be proposed in the presence of proven renal colic or urinary excretory tract lithiasis or nephrocalcinosis, 24h calciuria >250 mg/day (female) or >300 mg/day (male), or calcium >10 mg/L above high normal value" (Grade A++) 9.

Beware of "High-Normal" Calcium

In PHPT, a PTH level that is "normal" or "high-normal" in the context of elevated calcium is inappropriately elevated 3. The same applies to calcium—"high-normal" calcium with elevated PTH and high urinary calcium represents pathological hypercalcemia requiring treatment 1.

Recurrence Risk Without Surgery

Untreated PHPT with pancreatitis has a 100% mortality rate in historical series 8. Even with conservative management, mortality remains 93.5% without definitive parathyroidectomy 8. Your patient is at high risk for recurrent pancreatitis, which carries progressively worse outcomes and may lead to chronic pancreatitis with prolonged PHPT duration 4, 5.

Treatment Algorithm

1. Immediate stabilization if acute hypercalcemia:

   • Volume repletion with IV saline
   • Forced diuresis
   • Antiresorptive agents (bisphosphonates)
   • Consider hemodialysis if calcium >3.5 mmol/L 7

2. Urgent parathyroidectomy (within days to weeks after stabilization):

   • Definitive treatment for PHPT 9, 8
   • Only intervention that prevents recurrent pancreatitis 4, 5
   • Improves neuropsychiatric symptoms in 75% of patients 6

3. Preoperative localization:

   • Sestamibi scan and/or 4D-CT 3
   • Proceed to surgery even if imaging is equivocal when clinical/biochemical evidence is strong 4

Common Pitfalls to Avoid

• Don't delay surgery for "watchful waiting" in symptomatic PHPT—this led to recurrent pancreatitis in documented cases 4
• Don't dismiss "high-normal" calcium as benign in the context of elevated PTH and symptoms
• Don't attribute all symptoms to PTH alone—the calcium is driving the acute, dangerous manifestations
• Don't wait for imaging confirmation if biochemistry clearly indicates PHPT and patient is symptomatic 4

The 2025 guidelines explicitly state that neurocognitive manifestations and quality of life issues "are not currently consensual criteria for surgical indications" when isolated 1, but your patient has multiple established surgical indications (pancreatitis, elevated urinary calcium, neurological symptoms suggesting severe disease) that mandate intervention 9.